Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China flag China · Delayed Price · Currency is CNY
39.84
+0.54 (1.37%)
May 6, 2026, 3:00 PM CST

SHA:603392 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,3592,4352,3883,8195,1931,416
Short-Term Investments
3481,168480--200
Trading Asset Securities
1,6011,4472,5102,0552,00940.39
Cash & Short-Term Investments
4,3095,0505,3785,8747,2011,656
Cash Growth
-6.92%-6.10%-8.44%-18.43%334.83%103.56%
Accounts Receivable
1,5271,6382,0642,9993,9602,277
Other Receivables
18.4897.6435.9648.715.1512.45
Receivables
1,5451,7382,1043,0533,9702,292
Inventory
767.06702.08863.19905.48869.14593.17
Other Current Assets
109.6836.5729.44469.42139.4105.2
Total Current Assets
6,7317,5268,37510,30212,1804,647
Property, Plant & Equipment
3,4933,5183,5382,6412,2351,703
Long-Term Investments
1,7921,2921,36212.01911.361.3
Other Intangible Assets
781.19797.38512.46508.28292.5289.92
Long-Term Deferred Tax Assets
359.3338.18243.33157.9566.0168.97
Long-Term Deferred Charges
357.38292.39363.85214.29172.3727.18
Other Long-Term Assets
248.06280.67294.671,879372.3249.09
Total Assets
13,76114,04414,68915,71516,2307,046
Accounts Payable
452.28143.61137.94234.28275.47154.08
Accrued Expenses
108.18641.71915.891,6532,5721,541
Short-Term Debt
147.57133.66103.6281.14140.14235.64
Current Portion of Long-Term Debt
101.8656.8565.6887.193.07-
Current Portion of Leases
-19.5238.4313.313.7313.93
Current Income Taxes Payable
20.070.438.597.4999.02146.55
Current Unearned Revenue
37.9741.0548.1570.3882.2870.3
Other Current Liabilities
730.13765.4693.76523.42299.34204.64
Total Current Liabilities
1,5981,8022,0122,6703,4852,366
Long-Term Debt
58.8698.7994.19115.36102.494.9
Long-Term Leases
46.7445.5780.9712.3618.4332.59
Long-Term Unearned Revenue
69.1564.3954.233.6541.3776.44
Long-Term Deferred Tax Liabilities
----17.15-
Other Long-Term Liabilities
-----3.8
Total Liabilities
1,7732,0112,2412,8313,6652,483
Common Stock
1,2641,2641,2651,268906.07607.04
Additional Paid-In Capital
3,0483,0483,1393,3123,729445.83
Retained Earnings
7,5097,5527,9508,2507,9063,413
Treasury Stock
---92.17-129.42-200.17-
Total Common Equity
11,82211,86512,26312,70112,3414,466
Minority Interest
166.56168.46185.16183.06223.6396.2
Shareholders' Equity
11,98812,03312,44812,88412,5654,562
Total Liabilities & Equity
13,76114,04414,68915,71516,2307,046
Total Debt
355.03354.39382.91309.35277.86287.06
Net Cash (Debt)
3,9544,6954,9955,5656,9231,369
Net Cash Growth
-7.12%-6.00%-10.23%-19.63%405.71%86.03%
Net Cash Per Share
3.013.653.764.425.541.11
Filing Date Shares Outstanding
1,2641,2641,2651,2681,2681,232
Total Common Shares Outstanding
1,2641,2641,2651,2681,2681,232
Working Capital
5,1335,7246,3637,6328,6952,281
Book Value Per Share
9.359.389.6910.019.733.62
Tangible Book Value
11,04011,06711,75012,19212,0494,176
Tangible Book Value Per Share
8.738.759.299.619.503.39
Buildings
-1,557779.65724.87628.89392.67
Machinery
-2,1271,7641,5101,185666.87
Construction In Progress
-571.791,469814.56720.51924.38
Source: S&P Global Market Intelligence. Standard template. Financial Sources.